other material
confidence high
sentiment positive
materiality 0.75
DarioHealth closes $25.6M private placement; targets cash flow positive by end of 2025
DarioHealth Corp.
- Raised $25.6M via convertible preferred stock at conversion prices of $0.73 and $0.83; majority from existing shareholders.
- Pro forma cash balance of $40.6M as of Q3 2024; aims to achieve operational cash flow positive run rate by end of 2025.
- Preferred stock pays 10% quarterly stock dividend for first four quarters; conversion subject to stockholder approval.
- Lock-up agreements with Series B & C preferred holders to receive up to 40% additional common shares over 12 months.